In agreement with the decreased expression in our results, CXCL6 is decreased in the CSF of patients experiencing primary progressive aphasia, a sporadic neurodegenerative disease in the frontotemporal dementia spectrum associated with neuroinflammation [36]. Here, CXCL6 is linked to neurodegenerative disease.